Stock vs Stock Comparison

EMCOR Group, Inc. vs Arcosa, Inc.

EME wins the Tale of the Tape 7–2.

EME$839.54
ACA

🏆 Tale of the Tape

72
EMEACA
7.5%Profitability (Net Margin)7.2%
27.8xValuation (P/E)28.3x
30.9%Efficiency (ROIC)6.2%
5/9Health (Piotroski F)8/9
7.3Safety (Altman Z)
16.6%Growth (Rev YoY)12.2%
2.00Risk (Sharpe 1Y)
1.53xBalance Sheet (D/E)0.89x
3.42%FCF Yield

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricEMEACA
Market Cap$36.8B$5.9B
P/E Ratio27.8x28.3x
Forward P/E25.3x22.4x
P/B9.50x2.23x
Dividend Yield0.16%0.17%
Beta1.170.96

Quantitative Metrics

MetricEMEACA
DCF Fair Value$704.33$99.96
DCF Upside-13.3%
Piotroski F5/98/9
Altman Z7.32
Beneish M-2.25-2.48
FCF Yield3.42%
Net Debt/EBITDA2.3x
ROIC30.9%6.2%
WACC
ROIC – WACC
Gross Margin19.3%22.4%
Net Margin7.5%7.2%
Rev Growth YoY16.6%12.2%
Sharpe (1Y)2.00
Max Drawdown 3Y-36.2%
FCF Payout Ratio4%6%

EME Price

Loading chart...

ACA Price

Loading chart...

ETF Exposure

EME found in:

XLI0.72%
VBK0.58%
VIS0.57%
ONEV0.53%
SMMD0.51%
VB0.51%
ONEO0.46%
VBR0.45%
VFQY0.27%
RSP0.22%
SCHG0.12%
SPYG0.11%
QUS0.10%
VONV0.08%
IWD0.07%
VOO0.06%
VONE0.06%
VTI0.06%
SPY0.06%
SPLG0.06%
SPTM0.06%
SCHX0.05%
SCHB0.05%
IVV0.05%
ITOT0.04%
IWF0.04%
VT0.04%
VONG0.04%
URTH0.04%
ACWI0.03%

ACA found in:

SLYG0.45%
SPSM0.35%
SLYV0.25%
VTWO0.18%
VFMO0.15%
VBR0.14%
VGK0.12%
VYMI0.10%
VIS0.09%
SPDW0.08%
VB0.08%
VXF0.08%
VEA0.06%
VSGX0.06%
CWI0.05%
VEU0.05%
VXUS0.04%
SPTM0.01%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

EME vs ACA: Head-to-Head Analysis

EMCOR Group, Inc. (EME) and Arcosa, Inc. (ACA) represent two companies in the Industrials sector. In our quantitative Tale of the Tape scoring, EME leads 7–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, EME generates a return on invested capital (ROIC) of 30.9% compared to ACA's 6.2%. This suggests EME is more effective at deploying capital to generate shareholder returns.

EME appears in 30 ETFs tracked by SecuritiesDB, while ACA appears in 18 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, EME or ACA?

Our quantitative analysis compares EME and ACA across nine fundamental dimensions. EME wins the Tale of the Tape 7–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are EME and ACA correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.